0.572

-0.012 (-2.05%)
Range 0.570 - 0.584   (2.46%)
Open 0.581
Previous Close 0.584
Buy Price 0.572
Buy Volume 13
Sell Price 0.572
Sell Volume 10
Volume 603,997
Value -
Remark
Measurement Type Value
EPS (USD) -0.559
Trailing EPS (USD) -0.484
NAV (USD) 0.369
Cash In Hand (USD) 0.373
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 1.584
Price / Cash In Hand 1.565
Issued & Paid-up Shares 21,171,800
Treasury Shares -
Market Cap (M) 12.364
Par Value (USD) n.a.
Beta - 75 Days -0.42
R-Squared - 75 Days(%) 0.54
Beta - 500 Days 2.19
R-Squared - 500 Days(%) 0.06
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 28 Nov 2020 01:59.
Data powered by
View All Events

About INVIVO THERAPEUTICS HOLDING CORP

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc. is a medical device company engaged in developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries and also to develop its novel Neuro-Spinal Scaffold to treat acute SCI and Neuro-Scaffold Plus Stem Cells to treat chronic SCI. The Company�s Bioresorbable Polymer Scaffold Device is a bioresorbable material that will be inserted into the spinal cord at the center of the site of injury. Its Bioresorbable Hydrogels is for the controlled release of small molecules and proteins.

Loading Chart...